Developments Fluidigm introduces new immune profiling system Fluidigm’s (NASDAQ:FLDM) new immune profiling system, Maxpar Direct, quantifies immune cell populations with automated five-minute results reporting. Maxpar Direct uses a single-tube workflow to profile 37 different... March 28, 2019